Suppr超能文献

核糖体蛋白S6激酶1信号通路调节哺乳动物寿命。

Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.

作者信息

Selman Colin, Tullet Jennifer M A, Wieser Daniela, Irvine Elaine, Lingard Steven J, Choudhury Agharul I, Claret Marc, Al-Qassab Hind, Carmignac Danielle, Ramadani Faruk, Woods Angela, Robinson Iain C A, Schuster Eugene, Batterham Rachel L, Kozma Sara C, Thomas George, Carling David, Okkenhaug Klaus, Thornton Janet M, Partridge Linda, Gems David, Withers Dominic J

机构信息

Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK.

出版信息

Science. 2009 Oct 2;326(5949):140-4. doi: 10.1126/science.1177221.

Abstract

Caloric restriction (CR) protects against aging and disease, but the mechanisms by which this affects mammalian life span are unclear. We show in mice that deletion of ribosomal S6 protein kinase 1 (S6K1), a component of the nutrient-responsive mTOR (mammalian target of rapamycin) signaling pathway, led to increased life span and resistance to age-related pathologies, such as bone, immune, and motor dysfunction and loss of insulin sensitivity. Deletion of S6K1 induced gene expression patterns similar to those seen in CR or with pharmacological activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), a conserved regulator of the metabolic response to CR. Our results demonstrate that S6K1 influences healthy mammalian life-span and suggest that therapeutic manipulation of S6K1 and AMPK might mimic CR and could provide broad protection against diseases of aging.

摘要

热量限制(CR)可预防衰老和疾病,但其影响哺乳动物寿命的机制尚不清楚。我们在小鼠中发现,核糖体S6蛋白激酶1(S6K1)缺失,营养反应性mTOR(雷帕霉素哺乳动物靶标)信号通路的一个组成部分,导致寿命延长,并对与年龄相关的病理状况产生抗性,如骨骼、免疫和运动功能障碍以及胰岛素敏感性丧失。S6K1缺失诱导的基因表达模式类似于在热量限制或用腺苷单磷酸(AMP)激活的蛋白激酶(AMPK)进行药理学激活时所观察到的模式,AMPK是对热量限制的代谢反应的保守调节因子。我们的结果表明,S6K1影响健康的哺乳动物寿命,并表明对S6K1和AMPK的治疗性操作可能模拟热量限制,并可为衰老相关疾病提供广泛的保护。

相似文献

1
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.
Science. 2009 Oct 2;326(5949):140-4. doi: 10.1126/science.1177221.
2
Cell signaling. Aging is RSKy business.
Science. 2009 Oct 2;326(5949):55-6. doi: 10.1126/science.1181034.
5
S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover.
Am J Physiol Cell Physiol. 2007 Aug;293(2):C712-22. doi: 10.1152/ajpcell.00499.2006. Epub 2007 May 9.
7
AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
BMC Endocr Disord. 2015 Mar 27;15:11. doi: 10.1186/s12902-015-0010-9.
8
Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
J Biol Chem. 2004 Dec 24;279(52):54103-9. doi: 10.1074/jbc.M410755200. Epub 2004 Oct 19.
10
PAS kinase is a nutrient and energy sensor in hypothalamic areas required for the normal function of AMPK and mTOR/S6K1.
Mol Neurobiol. 2014 Oct;50(2):314-26. doi: 10.1007/s12035-013-8630-4. Epub 2014 Jan 21.

引用本文的文献

1
A hierarchy of causes of death in senescent .
bioRxiv. 2025 Aug 25:2025.08.21.671442. doi: 10.1101/2025.08.21.671442.
2
An emerging role for cysteine-mediated redox signaling in aging.
Redox Biol. 2025 Aug 29;86:103852. doi: 10.1016/j.redox.2025.103852.
3
Loss of Pol III repressor Maf1 in neurons promotes longevity by preventing the age-related decline in 5S rRNA and translation.
PLoS Biol. 2025 Jul 15;23(7):e3003250. doi: 10.1371/journal.pbio.3003250. eCollection 2025 Jul.
4
The Role of S6K1 in Aging and Alzheimer's Disease: Mechanistic Insights and Therapeutic Potential.
Int J Mol Sci. 2025 Jun 20;26(13):5923. doi: 10.3390/ijms26135923.
5
Senotherapy for chronic lung disease.
Pharmacol Rev. 2025 May 28;77(4):100069. doi: 10.1016/j.pharmr.2025.100069.
6
mTOR promotes the formation and growth of tertiary lymphoid tissues in the kidney.
Front Immunol. 2025 May 27;16:1527817. doi: 10.3389/fimmu.2025.1527817. eCollection 2025.
8
Targeting the Electron Transport System for Enhanced Longevity.
Biomolecules. 2025 Apr 23;15(5):614. doi: 10.3390/biom15050614.
9
Recent Advances in Aging and Immunosenescence: Mechanisms and Therapeutic Strategies.
Cells. 2025 Mar 27;14(7):499. doi: 10.3390/cells14070499.

本文引用的文献

1
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.
Nature. 2009 Jul 16;460(7253):392-5. doi: 10.1038/nature08221. Epub 2009 Jul 8.
2
The TOR pathway comes of age.
Biochim Biophys Acta. 2009 Oct;1790(10):1067-74. doi: 10.1016/j.bbagen.2009.06.007. Epub 2009 Jun 16.
3
AMPK: an emerging drug target for diabetes and the metabolic syndrome.
Cell Metab. 2009 May;9(5):407-16. doi: 10.1016/j.cmet.2009.03.012.
4
The pharmacology of mTOR inhibition.
Sci Signal. 2009 Apr 21;2(67):pe24. doi: 10.1126/scisignal.267pe24.
5
Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice.
J Pharmacol Sci. 2009 Apr;109(4):496-503. doi: 10.1254/jphs.08215fp.
6
Insulin sensitivity as a key mediator of growth hormone actions on longevity.
J Gerontol A Biol Sci Med Sci. 2009 May;64(5):516-21. doi: 10.1093/gerona/glp024. Epub 2009 Mar 20.
7
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.
Nature. 2009 Apr 23;458(7241):1056-60. doi: 10.1038/nature07813.
8
Metformin slows down aging and extends life span of female SHR mice.
Cell Cycle. 2008 Sep 1;7(17):2769-73. doi: 10.4161/cc.7.17.6625. Epub 2008 Sep 11.
9
AMPK and PPARdelta agonists are exercise mimetics.
Cell. 2008 Aug 8;134(3):405-15. doi: 10.1016/j.cell.2008.06.051. Epub 2008 Jul 31.
10
Aging and survival: the genetics of life span extension by dietary restriction.
Annu Rev Biochem. 2008;77:727-54. doi: 10.1146/annurev.biochem.77.061206.171059.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验